An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-24-3174
Affiliations:
13
Authors:
34
Go to article
Institutions Authors Share
King's College London (KCL), United Kingdom (UK)
9.583333
 0.28
SeromYx Systems, United States of America (USA)
6.000000
 0.18
Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)
5.166667
 0.15
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)
4.333333
 0.13
Ludger Ltd., United Kingdom (UK)
4.000000
 0.12
Breast Cancer Now King's College London Research Unit (BCN-KCL), United Kingdom (UK)
3.583333
 0.11
The Institute of Cancer Research (ICR), United Kingdom (UK)
1.333333
 0.04
Interested in Oncology and Carcinogenesis?